Article

Immunogenicity of an AAV-based, room-temperature stable, single dose COVID-19 vaccine in mouse and non-human primates

2021-01-05

Abstract excerpt

<h4>Summary</h4> The SARS-CoV-2 pandemic has affected more than 70 million people worldwide and resulted in over 1.5 million deaths. A broad deployment of effective immunization campaigns to achieve population immunity at global scale will depend on the biological and logistical attributes of the vaccine. Here, two adeno-associated viral (AAV)-based vaccine candidates demonstrate potent immunogenicity in mouse an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 75b86f66-dec1-534f-b7c6-13c5272e135b
DOI: 10.1101/2021.01.05.422952

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Immunogenicity of an AAV-based, room-temperature stable, single dose COVID-19 vaccine in mouse and non-human primatesDOI 10.1101/2021.01.05.422952Read

An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primatesSemantic proximity Read

Single-shot rAAV5-based Vaccine Provides Long-term Protective Immunity against SARS-CoV-2 and Its VariantsSemantic proximity Read

A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stabilitySemantic proximity Read

Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and SafetySemantic proximity Read

Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19Semantic proximity Read

Translational Virology - COVID-19, The Perfect ExampleSemantic proximity Read

A novel intranasal administration adenoviral vector-based platform for rapid COVID-19 vaccine developmentSemantic proximity Read

Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunitySemantic proximity Read

Single-dose AAV-based vaccine induces a high level of neutralizing antibodies against SARS-CoV-2 in rhesus macaquesSemantic proximity Read

Immunogenicity and efficacy of Ad26. COV2 .S: An adenoviral vector–based COVID ‐19 vaccineSemantic proximity Read

High efficacy of VLA2001 vaccine against SARS-CoV-2 infection in non-human primatesSemantic proximity Read

An intranasal vaccine durably protects against SARS-CoV-2 variants in miceSemantic proximity Read